Ketamine-assisted psychotherapy (KAP) shows promising effectiveness for depression, particularly treatment-resistant depression, though research is still evolving. Studies on the benefits of ketamine-assisted psychotherapy consistently show
Yes, accelerated Transcranial Magnetic Stimulation (TMS) therapy appears to be effective for depression based on recent research, though it’s still an evolving treatment approach. Research
Spravato®, an esketamine nasal spray, has demonstrated notable success rates in treating treatment-resistant depression. However, outcomes vary depending on the treatment phase and study parameters.
Like most mental health treatments, TMS (Transcranial Magnetic Stimulation) therapy may not work for everyone, but it can be effective for many people, particularly those
When considering Spravato® vs. Ketamine to treat depression, they both are effective, but they have some critical differences. Spravato® (esketamine) is the S-enantiomer of ketamine,
Deep TMS (Transcranial Magnetic Stimulation) therapy is a non-invasive brain stimulation treatment primarily used for depression and other mental health conditions. Deep TMS therapy uses
While Spravato shows promise for bipolar depression based on emerging evidence, it’s used off-label and is not currently FDA-approved for treating bipolar disorder. Despite the
Transcranial Magnetic Stimulation (TMS) therapy is generally well-tolerated, with most TMS therapy side effects being mild and temporary. The most common side effect is headache
Despite the lack of official approval, emerging research suggests potential benefits for patients using Spravato® for PTSD treatment. Also referred to as esketamine, a small
Ketamine-assisted couples therapy shows particular promise for couples facing relationship distress alongside mental health challenges. Research indicates this approach may be especially effective when one
